The Captial Market (CapitalMarket.com) rating for Niva Bupa Health Insurance IPO is 43. Their analysis recommends Avoid, However active risk seekers can try for the IPO.

Reviewer	Rating Score	Rating
Capital Market	43	Avoid, However active risk seekers can try

Niva Bupa Health Insurance IPO Review by Dilip Davda May apply

[Dilip Davda] The company is one of the leading health insurance company in India and has emerged as the fastest growing company. It turned the corner from FY23, but based on its earnings so far, the issue prima-facie appears aggressively priced. However, considering the recent placement of shares internally between Rs. 67.15 and Rs. 85 per share, the IPO appears well priced. Well-informed investors may park funds for medium to long term. Read detail review...

Niva Bupa Health Insurance IPO Peer Comparison

Niva Bupa Health Insurance Company Limited peer comparison with similar listed entities. (As on March 28, 2024)

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Niva Bupa Health Insurance Company Limited	0.51	0.5	12.06		5.68
Star Health and Allied Insurance Company Limited	14.48	14.19	108.35	36.97	14.35	5.03	Consolidated
Icici Lombard General Insurance Company Ltd	39.03	38.78	242.75	45.92	17.17	6.96	Consolidated
The New India Assurance Company Ltd	6.77	6.77	132.55	35.23	5.13	1.72	Consolidated

All the financial information for listed industry peers mentioned is on a consolidated basis (unless otherwise available only on standalone basis). It is sourced from the annual reports/ financial results/public disclosures submitted to stock exchanges or on the company's website, as available of the respective company for the year ended March 31, 2024.
New India Assurance Company Limited is strictly not comparable with the Company (This is for information purposes)
Net Worth is defined as share capital plus reserves and surplus less any debit balance in profit and loss account and miscellaneous expenditure.
P/E ratio for listed peers is calculated as closing share price (June 25, 2024, -BSE) / Diluted EPS for the year ended March 31, 2024,
NAV per equity share (?) = Net worth at the end of the year / Total number of equity shares outstanding as of March 31, 2024.

Niva Bupa Health Insurance IPO Review by Members

Niva Bupa Health Insurance IPO Reviews, analysis and views by popular members. Read Niva Bupa Health Insurance Co.Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Niva Bupa Health Insurance IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Niva Bupa Health Insurance IPO Review & Recommendations

Niva Bupa Health Insurance IPO Review Summary from brokers and analysts

Niva Bupa Health Insurance IPO Capital Market Rating

Niva Bupa Health Insurance IPO Review by Dilip Davda May apply

Niva Bupa Health Insurance IPO Peer Comparison

Niva Bupa Health Insurance IPO Review by Members

Niva Bupa Health Insurance IPO Review Summary by Members

Read more about Niva Bupa Health Insurance IPO